Indianapolis-based FAST BioMedical has named a veteran healthcare executive to its board of directors. Jim Dillon has more than 30 years in the healthcare sector. That as the company grows its laboratory space.
Dillon is currently chief executive officer of Reprieve Cardiovascular, a Massachusetts-based cardiac device company.
FAST Biomedical is a clinical-stage company developing tools to help patients facing heart failure.
Dillon was also an executive with Abiomed, an east coast company that develops and manufactures circulatory devices, such as heart pumps.
“I am a champion of FAST BioMedical’s technology and am thrilled to join its Board of Directors,” said Dillon. “With so little technological advancement in tools to manage patient’s fluid status, there is a huge unmet medical need for this first-in-class innovation. I firmly believe it can enable precision medicine to save lives,” said Dillon.
Meanwhile, FAST BioMedical recently moved its wet lab operations to the 16 Tech Innovation District on the west side of Indianapolis.
The district is a hub of scientific research, technology innovation and entrepreneurship.
“The move to 16 Tech enables us to deploy more devices in more hospitals for multiple clinical trials,” explained Dan Meier, PhD, vice president of product development for FAST BioMedical. “We will be able to provide a rapid processing of samples using our plasma volume and kidney function measurement technologies to trial sites around the world.”